New Horizons in HSCT-TMA: Expert Perspectives and Pearls for Practice
This live educational event is intended for learners to be better able to understand the dynamic data evaluating diagnostic and care strategies for hematopoi…
Related Articles
Association of p16(INK4a), a biomarker of cellular senescence, with receipt of therapy and frailty status among adults with plasma cell disorders
Multiple myeloma (MM) accounts for 19 % of hematologic malignancies diagnosed in the United States and has a higher incidence in older adults [1]. Treatment decision-making…
Like the EpiPen, but cheaper, smaller, and no needle
There’s been a fair amount of good news on the allergy front lately, including a medication for food allergies that we covered recently, and now…
A trial of radiolabeled antibody yttrium‐90–FF‐21101 for the treatment of advanced ovarian and other cancers
A clinical trial of yttrium-90–FF-21101 directed against P-cadherin did not meet predefined efficacy criteria. Because imaging studies indicated FF-21101 uptake by tumors, other warheads combined…
Experts Forecast Cancer Research and Treatment Advances in 2025
Researchers explain how precision medicine, immunotherapy, AI, treating blood cancers, and addressing cancer disparities may advance in 2025.
Endometrial Cancer Advances | Dana-Farber Cancer Institute
A new generation of drugs and drug combinations are improving the outlook for patients with endometrial (uterine) cancer.
NewsDetails
Rachel Darwin, Senior Manager, Public Relations Two-day symposium in Riyadh, Saudi Arabia brings together leading oncology professionals from across the MENA region to review updated…
Novel Agents May Enhance JAK Inhibitor Efficacy and Augment the Myelofibrosis Treatment Paradigm
Naseema Gangat, MBBS, discusses clinical factors that she uses to choose the optimal JAK inhibitors for individual patients with myelofibrosis.
No Improvement With Durvalumab vs Cetuximab in Advanced HNSCC
The NRG-HN004 trial showed that durvalumab did not improve outcomes vs cetuximab in locoregionally advanced head and neck squamous cell carcinoma undergoing radiotherapy with contraindications…
CD123 to the rescue
A 68-year-old woman with a history of discoid lupus erythematosus presented with multiple subcutaneous nodules on the breast and upper extremities. An incisional biopsy was…
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes
Key PointsB-PLL has a differential DNA methylation signature compared with CLL, MCL, and SMZL.Identification of 2 potential B-PLL subtypes with different b
